Back to Previous Page

Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 594 antibody produced in mouse clone 5D9

ITEM#: 3042-SAB5202422100UG

MFR#: SAB5202422-100UG

Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 594 antibody produced in mouse clone 5D9

See More Details
Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 594 antibody produced in mouse clone 5D9
Provide Content Correction
Product Name Description Item# QTY
Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 594 antibody produced in mouse clone 5E8 Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 594 antibody produced in mouse clone 5E8 3042-SAB5202440100UG EA
Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 390 antibody produced in mouse clone 5E8 Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 390 antibody produced in mouse clone 5E8 3042-SAB5202437100UG EA
Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 488 antibody produced in mouse clone 5E8 Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 488 antibody produced in mouse clone 5E8 3042-SAB5202438100UG EA
Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 488 antibody produced in mouse clone 5D9 Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 488 antibody produced in mouse clone 5D9 3042-SAB5202420100UG EA
Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 390 antibody produced in mouse clone 5D9 Monoclonal Anti-Hexanoyl-Lysine adduct-Atto 390 antibody produced in mouse clone 5D9 3042-SAB5202419100UG EA
Thank you for visiting. We look forward to serving you!

Read more about us:  Franklin Young Value



For Government, Military, Education and Government Prime Access:


New Customers Existing Customers

Please contact Customer Service with your questions.

Thank you for visiting, your account is pending approval.

You will received email notification for approval within 24hrs.

Contact customerservice@franklinyoung.com for any questions.

Thank you for requesting an account with Franklin Young.

Your request has been declined

We restrict website access to government entities, and related customers.

Please contact customerservice@franklinyoung.com with any questions.